Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer

A clinically applicable molecular-based classification for endometrial cancers

(2015) A Talhouk et al.   BRITISH JOURNAL OF CANCER

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

(2015) Ellen Stelloo et al.   MODERN PATHOLOGY

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma

(2015) Uwe Schirmer et al.   Oncotarget

L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results

(2014) T. Bosse et al.   EUROPEAN JOURNAL OF CANCER

Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT

(2014) Kai Doberstein et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

(2014) David N. Church et al.   JNCI-Journal of the National Cancer Institute

Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth

(2013) Dirk Weinspach et al.   CLINICAL & EXPERIMENTAL METASTASIS

L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer

(2013) Dong-liang Chen et al.   Journal of Hematology & Oncology

L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation

(2013) Alain G. Zeimet et al.   JNCI-Journal of the National Cancer Institute

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer

(2013) Tjalling Bosse et al.   MODERN PATHOLOGY

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival

(2012) Xiaodong Guo et al.   Diagnostic Pathology

Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K–AKT, Wnt/β-catenin and P53 pathway activation

(2012) Remi A. Nout et al.   GYNECOLOGIC ONCOLOGY

L1CAM

(2012) Helena Kiefel et al.   Cell Adhesion & Migration

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

(2011) Bo Li et al.   BMC BIOINFORMATICS

Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma

(2011) Heiner Schäfer et al.   CANCER LETTERS

L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma

(2011) Song-Yi Choi et al.   HUMAN PATHOLOGY

L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer

(2011) Verena Tischler et al.   Molecular Cancer

Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor  1- and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer

(2009) C. Geismann et al.   CANCER RESEARCH

Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas

(2009) Monica Huszar et al.   JOURNAL OF PATHOLOGY

Histologic and immunohistochemical decision-making in endometrial adenocarcinoma

(2008) Lesley Lomo et al.   MODERN PATHOLOGY